C6ORF130 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.404400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.599600E-01
Normal-vs-Stage2
1.748440E-01
Normal-vs-Stage3
1.003700E-02
Normal-vs-Stage4
9.814200E-01
Stage1-vs-Stage2
1.672590E-01
Stage1-vs-Stage3
4.285800E-02
Stage1-vs-Stage4
8.091400E-01
Stage2-vs-Stage3
1.151410E-01
Stage2-vs-Stage4
1.339810E-01
Stage3-vs-Stage4
7.468100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.784200E-01
Normal-vs-AfricanAmerican
4.685900E-02
Normal-vs-Asian
9.198400E-02
Caucasian-vs-AfricanAmerican
5.517200E-01
Caucasian-vs-Asian
2.932800E-01
AfricanAmerican-vs-Asian
8.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.557200E-01
Normal-vs-Female
1.092800E-01
Male-vs-Female
1.798410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.315180E-01
Normal-vs-Age(41-60Yrs)
4.136000E-01
Normal-vs-Age(61-80Yrs)
1.409620E-01
Normal-vs-Age(81-100Yrs)
4.696600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.197000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.685000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.481600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.976800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.111000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.317600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.297230E-01
Normal-vs-Daily Drinker
6.045700E-02
Normal-vs-Weekly Drinker
2.164200E-02
Normal-vs-Occasional Drinker
8.977600E-01
Normal-vs-Social Drinker
1.115750E-01
Non Drinker-vs-Daily Drinker
5.403600E-01
Non Drinker-vs-Weekly Drinker
1.967820E-01
Non Drinker-vs-Occasional Drinker
1.505220E-01
Non Drinker-vs-Social Drinker
8.165200E-01
Daily Drinker-vs-Weekly Drinker
4.402800E-01
Daily Drinker-vs-Occasional Drinker
8.517900E-02
Daily Drinker-vs-Social Drinker
4.253800E-01
Weekly Drinker-vs-Occasional Drinker
3.715700E-02
Weekly Drinker-vs-Social Drinker
1.349230E-01
Occasional Drinker-vs-Social Drinker
1.976050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.044200E-02
Normal-vs-Grade 2
5.241900E-02
Normal-vs-Grade 3
1.533760E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.459400E-01
Grade 1-vs-Grade 3
2.752000E-01
Grade 1-vs-Grade 4
2.044200E-02
Grade 2-vs-Grade 3
8.900800E-01
Grade 2-vs-Grade 4
5.241900E-02
Grade 3-vs-Grade 4
1.533760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.746200E-02
Normal-vs-NonDiabetic
2.619800E-01
Diabetic-vs-NonDiabetic
1.863030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.482900E-03
Normal-vs-NoPancreatitis
2.588200E-01
Pancreatitis-vs-NoPancreatitis
5.755700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.156600E-01
Normal-vs-N1
1.847840E-01
N0-vs-N1
2.012200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.266000E-01
Normal-vs-TP53-NonMutant
7.281400E-01
TP53-Mutant-vs-TP53-NonMutant
8.699400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
